Picture of Ion Beam Applications SA logo

IBAB Ion Beam Applications SA Share Price

0.000.00%
be flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+15.49%
3m+18.39%
6m+30.33%
1yr-22.97%
Volume Change (%)
10d/3m-3.73%
Price vs... (%)
52w High-22.91%
50d MA+15.33%
200d MA+17.88%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)23.24
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)3.01%
Valuation (ttm)IndustryMarket
Price to Book Value3.64
Price to Tang. Book4.66
Price to Free Cashflown/a
Price to Sales0.9
EV to EBITDA19.12

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital3.51%
Return on Equity-8.2%
Operating Margin1.19%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m282.55311.95312.96361.27428.72494.55572.810.74%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/a-87.56+136.83n/an/a+158.44n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Ion Beam Applications SA EPS forecast chart

Profile Summary

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
March 28th, 1986
Public Since
June 13th, 1998
No. of Employees
1,845
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
be flag iconEuronext - Brussels
Shares in Issue
29,119,464

IBAB Share Price Performance

Upcoming Events for IBAB

Q1 2024 Ion Beam Applications SA Earnings Release and Busniess Update

Q2 2024 Ion Beam Applications SA Earnings Release

Similar to IBAB

Picture of Agfa Gevaert NV logo

Agfa Gevaert NV

be flag iconEuronext - Brussels

Picture of Biocartis NV logo

Biocartis NV

be flag iconEuronext - Brussels

Picture of Nyxoah SA logo

Nyxoah SA

be flag iconEuronext - Brussels

Picture of Onward Medical NV logo

Onward Medical NV

be flag iconEuronext - Brussels

FAQ